Healthtech Startups

Atalanta is developing treatment options for intractable central nervous system diseases using RNA interference technology. The company was founded by leading experts in RNAi research.

4 investors

Atara Biotherapeutics develops allogeneic T-cell immunotherapies using its proprietary EBV T-cell platform to harness the immune system for treating disease. The company focuses on next-generation cell-based therapies designed for patients worldwide.

4 investors

Atavistik Bio develops selective allosteric therapeutics using a proprietary discovery platform designed to identify functional pockets across multiple protein classes, with an internal focus on rare hematology. The company is advancing multiple drug programs toward regulatory approval and clinical applications for patients with significant unmet medical needs.

4 investors

A wearable device company developing brain-sensing technology using nanotechnology for consumer use.

4 investors

Atom develops artificial limbs using AI and neural interfaces to restore physical ability for people with limb loss. The company is building prosthetic technology that reads and writes neural signals to provide motor control and sensation restoration.

4 investors

Attralus develops pan-amyloid removal (PAR) therapeutics — biologics and imaging agents designed to bind and remove toxic amyloid — to treat patients with systemic amyloidosis across all disease types and stages. The company operates in the biotech and drug development space targeting these progressive, often fatal diseases.

4 investors

aTyr is a clinical-stage biotechnology company developing therapies derived from tRNA synthetase biology to treat fibrosis and inflammation, with its lead candidate efzofitimod in clinical trials for interstitial lung disease. The company leverages a proprietary discovery platform targeting immune-mediated disorders in pulmonary and systemic conditions.

4 investors

Auransa is a clinical-stage, AI-native biopharma company that analyzes large human disease datasets to discover and develop novel cancer therapies. It works collaboratively with pharmaceutical companies and academic institutions to advance its drug discovery programs.

4 investors

Autonomize builds an AI operating layer for healthcare enterprises that structures unstructured data, grounds decisions in clinical and policy evidence, and orchestrates workflows through healthcare-native AI agents working alongside human experts. The platform transforms healthcare operations to be faster, more accurate, and continuously learning for payers and providers.

4 investors

AvaSure provides AI-powered virtual care technology for hospitals and health systems, aimed at protecting staff and improving patient safety and outcomes. Its solutions address the nursing workforce shortage through virtual nursing and video monitoring models.

4 investors

Avela Health provides virtual autism evaluations and therapy for children, teens, young adults, and their families, with services delivered by Master's or doctoral-level clinicians via video. It offers age-specific therapy programs, group support, school coordination, and specialty care, primarily serving families in New Jersey, Pennsylvania, and South Carolina.

4 investors

Avenda Health develops Unfold AI, deep learning software that maps a patient's prostate cancer in 3D to give physicians visualization and information for treatment planning. The company serves urologists and physicians treating prostate cancer patients in the medical device and healthcare space.

4 investors

Averna Therapeutics is a biotechnology company developing therapeutics. The page is a team bio profiling its CEO and board member.

4 investors

Aviary Health provides virtual and hybrid clinical programs — including cardiac rehabilitation, pulmonary rehabilitation, and chronic care management — combining AI-powered workflows with clinical teams. It serves hospitals and health systems, delivering end-to-end support for complex service lines.

4 investors

Biotechnology company developing immunomodulators using a HALOS nanotechnology platform for chronic inflammation.

4 investors

Avisi Technologies develops nanotechnology-enabled implantable devices to lower intraocular pressure in patients with open-angle glaucoma. Its products are investigational ophthalmic medical devices currently in clinical trials.

4 investors

Avoca provides an operational intelligence and automation layer for radiology clinic networks, handling patient calls, referrals, and bookings across channels 24/7 and integrating with existing RIS systems. It manages the patient journey from referral to results to help radiology providers capture demand, retain patients, and scale operations without adding headcount.

4 investors

Axena Health develops digital therapeutic devices for women's pelvic health, specifically treating urinary and fecal incontinence through at-home pelvic floor muscle training. The company serves women and their healthcare providers with FDA-cleared, prescription-based technology backed by peer-reviewed clinical evidence.

4 investors

Axithra, a spin-off from Ghent University's Photonics Research Group and imec, develops an optics- and photonics-based platform for therapeutic drug monitoring that measures and monitors drug concentrations in blood at the point of care. Its lead application targets personalizing β-lactam antibiotic treatment for patients in intensive care units.

4 investors

Ayble Health operates a personalized gastrointestinal care platform that integrates behavioral science and clinical protocols to improve outcomes for patients with GI conditions. The platform provides data-driven support beyond medication for conditions like ulcerative colitis and Crohn's disease.

4 investors

Azra AI provides a closed-loop patient management platform that tracks patients from clinical detection through completed care using structured workflows with defined ownership and measurable accountability. The platform integrates with leading EHRs and applies across oncology, cardiology, and other clinical service lines in health systems.

4 investors

Bain Capital Double Impact is an investment firm established in 2015 that funds companies generating both competitive financial returns and measurable social or environmental impact, with focus areas spanning healthcare access, economic opportunity, and environmental sustainability.

4 investors

Bairitone develops a wearable patch-based system that maps airway vibrations to detect sleep apnea obstruction causes without MRI, X-ray, or ultrasound. The platform provides dynamic airway mapping and precision therapy guidance for sleep health providers and patients.

4 investors

Basking Biosciences develops therapeutics for thrombosis, vascular biology, and ischemic disease. The company focuses on stroke and cardiovascular applications.

4 investors